FUJIFILM Cellular Dynamics (FCDI)

Madison, WI
Program data pending ClinicalTrials.gov matching
Not Assessed
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (7)

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesiPSC, iPSC-derived Cell Therapy, Cardiomyocytes, Neural Cells, Retinal Cells, NK Cells
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press7 articles
Broad modality coverage (6 modalities)

Recent News 7 articles

news Wed, 17 Fe
Century Therapeutics Significantly Expands Capabilities with New Operational, Laboratory and Manufacturing Facilities in Pennsylvania and New Jersey - PR Newswire
news Wed, 07 Ap
Engineered stem cells power expansive range of cancer therapies - Nature
news Wed, 02 Ap
About Cade Hildreth, Founder and President of BioInformant - BioInformant
news Tue, 20 Au
iPSC Market Leaders and their Business Models - BioInformant
news Mon, 17 Ma
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases - PR Newswire
news Mon, 04 Ju
Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media - PR Newswire
news Mon, 01 Ju
Bayer powers Versant cell therapy startup to $250M round - Fierce Biotech
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
iPSC CDMOs → iPSC-derived Cell Therapy CDMOs → Cardiomyocytes CDMOs → Neural Cells CDMOs → Retinal Cells CDMOs → NK Cells CDMOs →